- Home
- ADVB vs OXBR Comparison
ADVB vs OXBR Comparison
Compare ADVB & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADVB | OXBR |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | Hong Kong | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 7.7M |
| IPO Year | 2023 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ADVB | OXBR |
|---|---|---|
| Price | $2.27 | $0.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.5K | 18.0K |
| Earning Date | 11-18-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3431.25 | 37.78 |
| EPS | ★ 5.33 | 0.02 |
| Revenue | $127,637.00 | ★ $2,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.45 | $37.84 |
| Revenue Growth | N/A | ★ 371.98 |
| 52 Week Low | $2.25 | $0.65 |
| 52 Week High | $113.80 | $1.86 |
Technical Indicators
Market Signals| Indicator | ADVB | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 19.50 | 38.78 |
| Support Level | N/A | $0.72 |
| Resistance Level | $5.59 | $0.98 |
| Average True Range (ATR) | 0.59 | 0.12 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 2.54 | 30.40 |
Price Performance
Historical ComparisonAbout ADVB Advanced Biomed Inc.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a holding company operating complementary growth platforms across AI infrastructure and digital financial infrastructure. Through AI GridWorks, the Company is focused on developing, owning, and operating AI data centers and related infrastructure. Through SurancePlus and its reinsurance subsidiaries, Oxbridge provides tokenized real-world asset (RWA) securities and reinsurance solutions, including tokenized reinsurance offerings utilizing blockchain technology.